JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a report issued on Monday, MarketBeat reports. The firm issued a neutral rating and a $18.00 price objective on the stock.
Several other research firms have also recently weighed in on ARDT. Truist Financial started coverage on shares of Ardent Health Partners in a report on Monday. They set a buy rating and a $21.00 price target on the stock. SVB Leerink began coverage on Ardent Health Partners in a research note on Monday. They issued an outperform rating and a $23.00 target price on the stock. Finally, Mizuho started coverage on Ardent Health Partners in a research report on Monday. They set an outperform rating and a $20.00 price target for the company. One analyst has rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of Buy and an average price target of $21.70.
View Our Latest Report on ARDT
Ardent Health Partners Stock Up 6.1 %
Ardent Health Partners Company Profile
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
See Also
- Five stocks we like better than Ardent Health Partners
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- What is a Special Dividend?
- Jeff Brown’s Exegesis AI Stock Picks
- Investing In Preferred Stock vs. Common Stock
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.